UBC Medical Indonesia (IDX:LABS) - Stock Price, News & Analysis

LABS Stock Overview

Distributes medical devices in Indonesia.

LABS fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Rewards

Revenue grew by 46.5% over the past year

Risk Analysis

Highly volatile share price over the past 3 months

Interest payments are not well covered by earnings

High level of non-cash earnings

Profit margins (1.6%) are lower than last year (3%)

+ 1 more risk

PT UBC Medical Indonesia Tbk Competitors

Dosni Roha Indonesia

IDX:ZBRA

Rp446.9b

PT. Penta Valent

IDX:PEVE

Rp416.7b

Itama Ranoraya

IDX:IRRA

Rp753.9b

Millennium Pharmacon International

IDX:SDPC

Rp170.7b

Price History & Performance

Summary of all time highs, changes and price drops for UBC Medical Indonesia
Historical stock prices
Current Share Price	Rp144.00
52 Week High	Rp228.00
52 Week Low	Rp109.00
Beta	0
11 Month Change	4.35%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	5.11%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	LABS	ID Healthcare	ID Market
7D	4.3%	0.5%	2.5%
1Y	n/a	7.0%	11.8%

Return vs Industry: Insufficient data to determine how LABS performed against the ID Healthcare industry.

Return vs Market: Insufficient data to determine how LABS performed against the ID Market.

Price Volatility

Is LABS's price volatile compared to industry and market?
LABS volatility
LABS Average Weekly Movement	17.5%
Healthcare Industry Average Movement	6.4%
Market Average Movement	6.0%
10% most volatile stocks in ID Market	13.2%
10% least volatile stocks in ID Market	2.8%

Stable Share Price: LABS's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine LABS's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2014	64	Franciscus Yoshua Raintjung	www.ubcindonesia.com

PT UBC Medical Indonesia Tbk distributes medical devices in Indonesia. It operates in two segments, Medical Disposables and Consumables, and Diagnostics and Equipment. The company offers next generation molecular, retina AI, infectious disease, HPV DNA test, real time PCR, TB management, and newborn screening products.

PT UBC Medical Indonesia Tbk Fundamentals Summary

How do UBC Medical Indonesia's earnings and revenue compare to its market cap?
LABS fundamental statistics
Market cap	Rp584.60b
Earnings (TTM)	Rp2.19b
Revenue (TTM)	Rp136.70b

259.8x

P/E Ratio

4.2x

P/S Ratio

Is LABS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LABS income statement (TTM)
Revenue	Rp136.70b
Cost of Revenue	Rp82.14b
Gross Profit	Rp54.56b
Other Expenses	Rp52.37b
Earnings	Rp2.19b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	0.55
Gross Margin	39.92%
Net Profit Margin	1.60%
Debt/Equity Ratio	82.8%

How did LABS perform over the long term?

See historical performance and comparison